Active Surveillance Criteria for Low-Risk Prostate Cancer

Watching instead of treating

Low-risk prostate cancer is often indolent. Active surveillance monitors with periodic PSA, exam, and repeat biopsy rather than immediate surgery or radiation, avoiding treatment side effects.

Who qualifies

• Low Grade Group (Gleason 6) disease.
• Low PSA and limited clinical stage.
• Low tumor volume on biopsy.

Why staging still matters

Accurate TNM, Grade Group, and PSA keep risk stratification honest so that patients who progress are moved to definitive therapy without delay.